Brief: China Regenerative Medicine International enters into framework agreements
11/04/2016 24:19
April 11 (Reuters) - China Regenerative Medicine International Ltd 8158.HK : * Framework agreements in relation to Hainan Boao Regenerative Medicine Research and Clinical Centre Projects * Under framework agreements, the company will be responsible for construction, management and operation of the projects * Company entered into two non-legally-binding framework agreements * Source text for Eikon ID:nHKS8L5Fyw ((For more news, please click here 8158.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital